Siddharth Tewari | Sri Ramachandra Medical College And Research Instute (original) (raw)
Uploads
Papers by Siddharth Tewari
Research Journal of Pharmaceutical, Biological and Chemical Science, 2017
Malignant mixed mesodermal tumor (MMMT) of ovary accounts for less than 1% of all ovarian tumors.... more Malignant mixed mesodermal tumor (MMMT) of ovary accounts for less than 1% of all ovarian tumors. These aggressive tumors with malignant epithelial and sacromatous elements occur mainly in postmenopausal, low parity women These tumors have aggressive clinical course and very poor prognosis. We herein present a case of malignant mixed mesodermal tumor In a 57 year old postmenopausal woman who presented with complaints of pain and mass per abdomen with loss of appetite and progressive anemia for the last 15 days.There was no history of vaginal bleeding and no relevant past medical history. A large palpable mass in the pelvis was observed during examination. A contrast enhanced CT scan of abdomen revealed a large,complex abdominopelvic mass with multiple omental deposits along with gross ascites.Ascitic fluid cytology reported metastatic ovarian adenocarcinoma.The patient was planned for NeoAdjuvant chemotherapy to be followed by interval cytoreduction surgery and further adjuvant chemotherapy. At approximately 5 months postoperatively, the patient remains alive and recurrence free.
Research Journal of Pharmaceutical, Biological and Chemical Science, 2017
Malignant mixed mesodermal tumor (MMMT) of ovary accounts for less than 1% of all ovarian tumors.... more Malignant mixed mesodermal tumor (MMMT) of ovary accounts for less than 1% of all ovarian tumors. These aggressive tumors with malignant epithelial and sacromatous elements occur mainly in postmenopausal, low parity women These tumors have aggressive clinical course and very poor prognosis. We herein present a case of malignant mixed mesodermal tumor In a 57 year old postmenopausal woman who presented with complaints of pain and mass per abdomen with loss of appetite and progressive anemia for the last 15 days.There was no history of vaginal bleeding and no relevant past medical history. A large palpable mass in the pelvis was observed during examination. A contrast enhanced CT scan of abdomen revealed a large,complex abdominopelvic mass with multiple omental deposits along with gross ascites.Ascitic fluid cytology reported metastatic ovarian adenocarcinoma.The patient was planned for NeoAdjuvant chemotherapy to be followed by interval cytoreduction surgery and further adjuvant chemotherapy. At approximately 5 months postoperatively, the patient remains alive and recurrence free.